SMARCA4 is associated with mitotic spindle, apical junction, and PI3/AKT/mTOR signaling pathways; it is increased in many types of cancer and is reportedly associated with the poor prognosis in other cancers (Peng et al., 2021; Guerrero-Martínez and Reyes, 2018). Here, SMARCA4 is linked to cancer.